|
AU2005202592A1
|
|
Compounds, Methods and Pharmaceutical Compositions for Treating Cellular Damage, such as Neural or Cardiovascular Tissue Damage
|
|
WO2005053609A2
|
|
Methods of nad+-dependent deacetylase inhibitors
|
|
TW200600516A
|
|
Methods of cancer treatment using naaladase inhibitors
|
|
TW200600496A
|
|
Heterocyclicesters and amides
|
|
WO2004078180A2
|
|
Naaladase inhibitors for treating opioid tolerance
|
|
MXPA05009492A
|
|
Thiolactones.
|
|
US2004152745A1
|
|
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
AU2003286776A1
|
|
Novel inhibitors of dipeptidyl peptidase iv
|
|
US2004204340A1
|
|
Polyprolyl inhibitors of cyclophilin
|
|
IL164217D0
|
|
Pharmaceutical compositions containing water-soluble propofol and methods of administering same
|
|
AU2003216424A8
|
|
Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
|
|
US2005238616A1
|
|
Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
|
|
IL162692D0
|
|
Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
|
|
MXPA04006326A
|
|
Inhibitors of dipeptidyl peptidase iv.
|
|
AU2002360733A8
|
|
Substituted 4,9-dihydrocyclopenta(imn)phenanthridine-5-ones derivatives thereof and their uses
|
|
AU2002357003A8
|
|
Indoles as naaladase inhibitors
|
|
AU2002354957A1
|
|
Biocompatible polymer containing composition for treatment of prostate cancers
|
|
WO02096866A2
|
|
Thiolalkyl benzoic acid derivatives
|
|
CA2449019A1
|
|
Method for treating nerve injury caused by surgery
|
|
AU2613602A
|
|
Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
|
